The optimum method to determine the maximum tolerated activity for high activity Re186HEDP therapy with peripheral blood stem cell support for skeletal metastases from prostate cancer

Autoria(s): McCready, V.R.; O'Sullivan, Joe; Norman, A.; Treleaven, J.; Dearnaley, D.
Data(s)

2004
Identificador

http://pure.qub.ac.uk/portal/en/publications/the-optimum-method-to-determine-the-maximum-tolerated-activity-for-high-activity-re186hedp-therapy-with-peripheral-blood-stem-cell-support-for-skeletal-metastases-from-prostate-cancer(dbe03eaa-7b1b-422e-b622-01e9ce3674f0).html
Idioma(s)

eng
Direitos

info:eu-repo/semantics/restrictedAccess
Fonte

McCready , V R , O'Sullivan , J , Norman , A , Treleaven , J & Dearnaley , D 2004 , ' The optimum method to determine the maximum tolerated activity for high activity Re186HEDP therapy with peripheral blood stem cell support for skeletal metastases from prostate cancer ' European Journal of Nuclear Medicine and Molecular Imaging , vol 31 , pp. S480-S481 .
Tipo

article
Acesso ao item digital